Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-062135)

Filing Details

Accession Number:: 0001209191-14-062135
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-06 17:18:41
Reporting Period:: 2014-10-03

Filing Date:: 2014-10-06
Accepted Time:: 2014-10-06 17:18:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178879	Amicus Therapeutics Inc	FOLD	Pharmaceutical Preparations (2834)	200422823

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543031	Daphne Quimi	C/O Amicus Therapeutics 1 Cedar Brook Drive Cranbury NJ 08512	Vp Finance And Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-03	6,812	$7.00	56,812	No	4	P	Direct
Common Stock	Disposition	2014-10-03	6,812	$7.00	50,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2014-10-03	3,461	$0.00	3,461	$3.53
Common Stock	Stock Options (right to buy)	Disposition	2014-10-03	3,351	$0.00	3,351	$4.16

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,289	2014-01-28	2023-01-28	No	4	M	Direct
11,649	2013-11-01	2019-11-16	No	4	M	Direct

Footnotes

The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2014.